HRT Financial’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $911K | Buy |
+51,210
| New | +$911K | ﹤0.01% | 1105 |
|
|
2024
Q2 | – | Sell |
-88,730
| Closed | -$1.39M | – | 2646 |
|
|
2024
Q1 | $1.39M | Sell |
88,730
-88,121
| -50% | -$1.38M | 0.01% | 698 |
|
|
2023
Q4 | $2.64M | Buy |
176,851
+140,998
| +393% | +$2.1M | 0.02% | 506 |
|
|
2023
Q3 | $579K | Buy |
+35,853
| New | +$579K | 0.01% | 1190 |
|
|
2022
Q4 | – | Sell |
-25,908
| Closed | -$1.97M | – | 2718 |
|
|
2022
Q3 | $1.97M | Buy |
25,908
+21,723
| +519% | +$1.65M | 0.02% | 582 |
|
|
2022
Q2 | $290K | Buy |
+4,185
| New | +$290K | ﹤0.01% | 1985 |
|
|
2022
Q1 | – | Sell |
-28,671
| Closed | -$2.15M | – | 3320 |
|
|
2021
Q4 | $2.15M | Sell |
28,671
-20,055
| -41% | -$1.51M | 0.01% | 551 |
|
|
2021
Q3 | $5.66M | Buy |
+48,726
| New | +$5.66M | 0.03% | 265 |
|
|
2020
Q3 | – | Sell |
-49,088
| Closed | -$2.91M | – | 2113 |
|
|
2020
Q2 | $2.91M | Buy |
49,088
+42,509
| +646% | +$2.52M | 0.09% | 225 |
|
|
2020
Q1 | $443K | Buy |
+6,579
| New | +$443K | 0.03% | 338 |
|
|
2019
Q4 | – | Sell |
-19,436
| Closed | -$1.45M | – | 1412 |
|
|
2019
Q3 | $1.45M | Buy |
+19,436
| New | +$1.45M | 0.07% | 190 |
|